NEFL and Alzheimer disease: Finally, we observed that lower CBF was associated with higher levels of the neurodegeneration biomarker CSF NfL (r = −0.45; p = 0.005; pFDR = 0.019) (Figure 4A), but not with imaging neurodegeneration markers TIV‐adjusted hippocampal volume and AD signature (Figure 5B,C).